You can manage bookmarks using lists, please log in to your user account for this.
Media type:
E-Article
Title:
Skeletal muscle mass and sarcopenia can be determined with 1.5-T and 3-T neck MRI scans, in the event that no neck CT scan is performed
Contributor:
Zwart, Aniek T.;
Becker, Jan-Niklas;
Lamers, Maria J.;
Dierckx, Rudi A. J. O.;
de Bock, Geertruida H.;
Halmos, Gyorgy B.;
van der Hoorn, Anouk
imprint:
Springer Science and Business Media LLC, 2021
Description:
<jats:title>Abstract</jats:title><jats:sec>
<jats:title>Objectives</jats:title>
<jats:p>Cross-sectional area (CSA) measurements of the neck musculature at the level of third cervical vertebra (C3) on CT scans are used to diagnose radiological sarcopenia, which is related to multiple adverse outcomes in head and neck cancer (HNC) patients. Alternatively, these assessments are performed with neck MRI, which has not been validated so far. For that, the objective was to evaluate whether skeletal muscle mass and sarcopenia can be assessed on neck MRI scans.</jats:p>
</jats:sec><jats:sec>
<jats:title>Methods</jats:title>
<jats:p>HNC patients were included between November 2014 and November 2018 from a prospective data-biobank. CSAs of the neck musculature at the C3 level were measured on CT (<jats:italic>n</jats:italic> = 125) and MRI neck scans (<jats:italic>n</jats:italic> = 92 on 1.5-T, <jats:italic>n</jats:italic> = 33 on 3-T). Measurements were converted into skeletal muscle index (SMI), and sarcopenia was defined (SMI < 43.2 cm<jats:sup>2</jats:sup>/m<jats:sup>2</jats:sup>). Pearson correlation coefficients, Bland–Altman plots, McNemar test, Cohen’s kappa coefficients, and interclass correlation coefficients (ICCs) were estimated.</jats:p>
</jats:sec><jats:sec>
<jats:title>Results</jats:title>
<jats:p>CT and MRI correlated highly on CSA and SMI (<jats:italic>r</jats:italic> = 0.958–0.998, <jats:italic>p</jats:italic> < 0.001). The Bland–Altman plots showed a nihil mean ΔSMI (− 0.13–0.44 cm<jats:sup>2</jats:sup>/m<jats:sup>2</jats:sup>). There was no significant difference between CT and MRI in diagnosing sarcopenia (McNemar, <jats:italic>p</jats:italic> = 0.5–1.0). Agreement on sarcopenia diagnosis was good with <jats:italic>κ</jats:italic> = 0.956–0.978 and <jats:italic>κ</jats:italic> = 0.870–0.933, for 1.5-T and 3-T respectively. Observer ICCs in MRI were excellent. In general, T2-weighted images had the best correlation and agreement with CT.</jats:p>
</jats:sec><jats:sec>
<jats:title>Conclusions</jats:title>
<jats:p>Skeletal muscle mass and sarcopenia can interchangeably be assessed on CT and 1.5-T and 3-T MRI neck scans. This allows future clinical outcome assessment during treatment irrespective of used modality.</jats:p>
</jats:sec><jats:sec>
<jats:title>Key Points</jats:title>
<jats:p><jats:italic>• Screening for low amount of skeletal muscle mass is usually measured on neck CT scans and is highly clinical relevant as it is related to multiple adverse outcomes in head and neck cancer patients.</jats:italic></jats:p>
<jats:p><jats:italic>• We found that skeletal muscle mass and sarcopenia determined on CT and 1.5-T and 3-T MRI neck scans at the C3 level can be used interchangeably.</jats:italic></jats:p>
<jats:p><jats:italic>• When CT imaging of the neck is missing for skeletal muscle mass analysis, patients can be assessed with 1.5-T or 3-T neck MRIs.</jats:italic></jats:p>
</jats:sec>